Literature DB >> 22627770

Transmaternal cell flow leads to antigen-experienced cord blood.

Miranda P Dierselhuis1, Els C Blokland, Jos Pool, Ellen Schrama, Sicco A Scherjon, Els Goulmy.   

Abstract

Umbilical cord blood (UCB) is used for HSCT. It is known that UCB can comprise Ag-specific T cells. Here we question whether solely transmaternal cell flow may immunize UCB. Twenty-three female UCB samples were collected from healthy mothers and analyzed for minor histocompatibility Ag HY-specific responses. Forty-two of 104 tetramer(pos) T-cell clones, isolated from 16 of 17 UCB samples, showed male-specific lysis in vitro. Male microchimerism was present in 6 of 12 UCB samples analyzed. In conclusion, female UCB comprises HY-specific cytotoxic T cells. The immunization is presumably caused by transmaternal cell flow of male microchimerism present in the mother. The presence of immune cells in UCB that are not directed against maternal foreign Ags is remarkable and may explain the reported clinical observation of improved HSCT outcome with younger sibling donors.

Mesh:

Substances:

Year:  2012        PMID: 22627770     DOI: 10.1182/blood-2012-02-410571

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection.

Authors:  Michael Eikmans; Astrid G S van Halteren; Koen van Besien; Jon J van Rood; Jos J M Drabbels; Frans H J Claas
Journal:  Chimerism       Date:  2014

Review 2.  Bidirectional alloreactivity: A proposed microchimerism-based solution to the NIMA paradox.

Authors:  William J Burlingham; Gilles Benichou
Journal:  Chimerism       Date:  2012-04-01

Review 3.  Maternal microchimerism in biliary atresia: are maternal cells effector cells, targets, or just bystanders?

Authors:  Toshihiro Muraji
Journal:  Chimerism       Date:  2014-03-26

4.  Low prevalence of male microchimerism in women with Mayer-Rokitansky-Küster-Hauser syndrome.

Authors:  H E Peters; B N Johnson; E A Ehli; D Micha; M O Verhoeven; G E Davies; J J M L Dekker; A Overbeek; M H van den Berg; E van Dulmen-den Broeder; F E van Leeuwen; V Mijatovic; D I Boomsma; C B Lambalk
Journal:  Hum Reprod       Date:  2019-06-04       Impact factor: 6.918

5.  Savior Siblings Might Rescue Fetal Lethality But Not Adult Lymphoma in Irf2bp2-Null Mice.

Authors:  Ragnar O Vilmundarson; Niloufar Heydarikhorneh; An Duong; Tiffany Ho; Kianoosh Keyhanian; Fariborz Soheili; Hsiao-Huei Chen; Alexandre F R Stewart
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

6.  Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation.

Authors:  Christiane Dobbelstein; Kwang Woo Ahn; Michael Haagenson; Gregory A Hale; Jon J van Rood; David Miklos; Edmund K Waller; Stephen R Spellman; Marcelo Fernandez-Vina; Arnold Ganser; Mahmoud Aljurf; Martin Bornhaeuser; Vikas Gupta; Susan R Marino; Marilyn S Pollack; Vijay Reddy; Matthias Eder; Stephanie J Lee
Journal:  Biol Blood Marrow Transplant       Date:  2013-02-01       Impact factor: 5.742

7.  Donor parity no longer a barrier for female-to-male hematopoietic stem cell transplantation.

Authors:  Astrid G S van Halteren; Miranda P Dierselhuis; Tanja Netelenbos; Mirjam Fechter
Journal:  Chimerism       Date:  2014

8.  Microchimerism of male origin in a cohort of Danish girls.

Authors:  Amanda Cecilie Müller; Marianne Antonius Jakobsen; Torben Barington; Allan Arthur Vaag; Louise Groth Grunnet; Sjurdur Frodi Olsen; Mads Kamper-Jørgensen
Journal:  Chimerism       Date:  2016-08-11

9.  We are all born as microchimera.

Authors:  Miranda P Dierselhuis; Els Goulmy
Journal:  Chimerism       Date:  2012-12-21

10.  The health effects of fetal microchimerism can be modeled in companion dogs.

Authors:  Senthil R Kumar; Sarah A Hansen; Sandra M Axiak-Bechtel; Jeffrey N Bryan
Journal:  Chimerism       Date:  2013-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.